OrbiMed’s CVS Health CVS Stock Holding History

OrbiMed’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-793,800	Closed	-$52M	–	131
2018 Q4	$52M	Buy	+793,800	New	+$59.3M	0.96%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OrbiMed's CVS Position: Q1 2019 in Review

OrbiMed sold out of CVS Health (CVS) in Q1 2019, closing a stake of 793,800 shares — an estimated $52M sold.

OrbiMed first reported a position in CVS in Q4 2018 and held it in 1 quarter. The position peaked at $52M in Q4 2018. 1,708 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

OrbiMed reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
OrbiMed sold 793,800 CVS Health shares in Q1 2019, an estimated $52M.
OrbiMed first reported a position in CVS Health in Q4 2018 and held it in 1 quarter.
OrbiMed's CVS Health position peaked at $52M in Q4 2018.
1,708 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.